These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10844103)

  • 41. Comparison of rimonabant and sibutramine treatment effects on food compulsion in rats.
    Menezes HS; Ciulla V; Camargo PS; Correa CA; Oliveira TM
    Acta Cir Bras; 2009; 24(6):454-9. PubMed ID: 20011830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of sibutramine on 5-hydroxyindole acetic acid levels and selected oxidative biomarkers on brain regions of female rats in the presence of zinc.
    Guzmán DC; García EH; Mejía GB; Olguín HJ; Jiménez FT; Soto EB; Del Angel DS; Aparicio LC
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):421-6. PubMed ID: 22141426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents.
    Heal DJ; Cheetham SC; Prow MR; Martin KF; Buckett WR
    Br J Pharmacol; 1998 Sep; 125(2):301-8. PubMed ID: 9786502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride.
    Luscombe GP; Hopcroft RH; Thomas PC; Buckett WR
    Neuropharmacology; 1989 Feb; 28(2):129-34. PubMed ID: 2541365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of metabolites of sibutramine in primary cultures of rat hepatocytes by liquid chromatography-ion trap mass spectrometry.
    Hakala KS; Link M; Szotakova B; Skalova L; Kostiainen R; Ketola RA
    Anal Bioanal Chem; 2009 Feb; 393(4):1327-36. PubMed ID: 19066859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.
    Talbot PS; Bradley S; Clarke CP; Babalola KO; Philipp AW; Brown G; McMahon AW; Matthews JC
    Neuropsychopharmacology; 2010 Feb; 35(3):741-51. PubMed ID: 19890256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.
    Barkeling B; Elfhag K; Rooth P; Rössner S
    Int J Obes Relat Metab Disord; 2003 Jun; 27(6):693-700. PubMed ID: 12833113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic treatment with D-fenfluramine, but not sibutramine, blocks cue-induced reinstatement of food-seeking behavior in the rat.
    Pratt WE; Ford RT
    Neurosci Lett; 2013 Nov; 556():232-7. PubMed ID: 24157852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enantioselective determination of sibutramine and its active metabolites in human plasma.
    Kang W; Bae K; Noh K
    J Pharm Biomed Anal; 2010 Jan; 51(1):264-7. PubMed ID: 19683887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
    Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects.
    Chung JY; Jang SB; Lee YJ; Park MS; Park K
    J Clin Pharmacol; 2011 Jan; 51(1):53-9. PubMed ID: 20350955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral mechanisms of sibutramine involving proximal gastric motility in dogs.
    Xu J; Chen JD
    Obesity (Silver Spring); 2006 Aug; 14(8):1363-70. PubMed ID: 16988078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sibutramine-dependent brown fat activation in rats: an immunohistochemical study.
    Giordano A; Centemeri C; Zingaretti MC; Cinti S
    Int J Obes Relat Metab Disord; 2002 Mar; 26(3):354-60. PubMed ID: 11896490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
    Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
    Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum.
    Fletcher PC; Napolitano A; Skeggs A; Miller SR; Delafont B; Cambridge VC; de Wit S; Nathan PJ; Brooke A; O'Rahilly S; Farooqi IS; Bullmore ET
    J Neurosci; 2010 Oct; 30(43):14346-55. PubMed ID: 20980590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The discovery and status of sibutramine as an anti-obesity drug.
    Luque CA; Rey JA
    Eur J Pharmacol; 2002 Apr; 440(2-3):119-28. PubMed ID: 12007530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines.
    Cole JO; Levin A; Beake B; Kaiser PE; Scheinbaum ML
    J Clin Psychopharmacol; 1998 Jun; 18(3):231-6. PubMed ID: 9617982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sibutramine provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species.
    Morikawa Y; Shibata A; Okumura N; Ikari A; Sasajima Y; Suenami K; Sato K; Takekoshi Y; El-Kabbani O; Matsunaga T
    Toxicol Appl Pharmacol; 2017 Jan; 314():1-11. PubMed ID: 27838152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.